Gan Su Min Hai Pharmaceuticals Ltd.
Gan Su Min Hai Pharmaceuticals Ltd., headquartered in Gansu Province, China, is a prominent player in the pharmaceutical industry, specialising in the research, development, and manufacturing of high-quality medicinal products. Founded in 2001, the company has achieved significant milestones, establishing a strong presence in both domestic and international markets. With a focus on traditional Chinese medicine and modern pharmaceutical innovations, Gan Su Min Hai offers a diverse range of products, including herbal remedies and prescription medications. Their commitment to quality and efficacy sets them apart in a competitive landscape. Recognised for their contributions to healthcare, Gan Su Min Hai Pharmaceuticals has garnered a reputation for excellence, positioning itself as a trusted name in the industry. The company continues to expand its operational reach, aiming to enhance global health outcomes through its unique offerings.
DitchCarbon Score
How does Gan Su Min Hai Pharmaceuticals Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Gan Su Min Hai Pharmaceuticals Ltd.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Gan Su Min Hai Pharmaceuticals Ltd.'s reported carbon emissions
Gan Su Min Hai Pharmaceuticals Ltd. currently does not have available carbon emissions data, as no specific figures have been provided. Consequently, there are no reported emissions for the most recent year or any previous years, including Scope 1, 2, or 3 emissions. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi), nor have they made any climate pledges. This lack of publicly available information suggests that Gan Su Min Hai Pharmaceuticals Ltd. may still be in the early stages of developing a comprehensive climate strategy or reporting framework. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of addressing carbon emissions and committing to sustainability initiatives. As such, it may be beneficial for Gan Su Min Hai Pharmaceuticals Ltd. to consider establishing measurable targets and transparent reporting practices to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Gan Su Min Hai Pharmaceuticals Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
